Immunofluorescent investigations in cutaneous vasculitis. I. Histotopical demonstration of complement/complement factors.

F Weidner
Author Information

Abstract

Using an indirect double layer immunofluorescence method, fresh skin lesions of 10 patients with different forms of cutaneous vasculitis were tested for the occurrence of complement-factors C1q (C1), alpha2D(C3) and beta1F (C5). In contrast to the irregularly found complement fixing immunoglobulins IgG and IgM, complement could be regularly seen bound to the cutaneous vessel walls; mostly the C3-factor alpha2D. C1q was demonstrable, combined with IgG and/or IgM only in 2 cases. In 5 patients there was a non-homogenous, roddy fluorescenece of the epidermal basal membrane zone and the cutaneous vessels, when alpha2D or beta1F were tested. Our findings suggest that the "alternate pathway" beginning with C3-activation is followed in most cases, whereas a typical "immune complex vasculitis" is obviously rare. The constant occurrence of complement in the cutaneous vessel walls of vascultis lesions is consistent with the known chemotactic and destructive role of complement factors in experimental models of angiitis, but it may not necessarily involve a specific immunological process.

References

  1. J Invest Dermatol. 1974 Aug;63(2):219-26 [PMID: 4152325]
  2. Dermatologica. 1964;129:217-31 [PMID: 14234635]
  3. Arch Dermatol Forsch. 1974;249(2):91-8 [PMID: 4138627]
  4. Arch Dermatol. 1971 Jan;103(1):24-32 [PMID: 4099590]
  5. Dermatologica. 1972;145(1):1-8 [PMID: 4572492]
  6. Proc Soc Exp Biol Med. 1954 Aug-Sep;86(4):789-94 [PMID: 13204357]
  7. Br J Dermatol. 1965 Apr;77:211-20 [PMID: 14278795]
  8. Br J Dermatol. 1971 Jun;84(6):523-33 [PMID: 4934044]
  9. Schweiz Med Wochenschr. 1956 Jul 14;86(28):799-805 [PMID: 13351591]
  10. J Exp Med. 1965 Feb 1;121:215-34 [PMID: 14264268]
  11. Lancet. 1964 Jul 25;2(7352):178-80 [PMID: 14163132]
  12. Arch Dermatol. 1973 Jul;108(1):114-8 [PMID: 4146100]
  13. Br J Dermatol. 1969 Jul;81(7):493-503 [PMID: 4183364]
  14. J Exp Med. 1959 Sep 1;110:481-94 [PMID: 13810816]
  15. Hautarzt. 1967 Jul;18(7):293-8 contd [PMID: 5598927]
  16. Hautarzt. 1972 Jan;23(1):1-8 [PMID: 4112804]
  17. J Invest Dermatol. 1966 Jan;46(1):1-5 [PMID: 5325995]
  18. Br J Dermatol. 1972 Nov;87(5):466-74 [PMID: 4567097]
  19. Immunology. 1970 Dec;19(6):909-19 [PMID: 4098878]
  20. Arch Klin Exp Dermatol. 1970;237(1):59-61 [PMID: 4906818]
  21. Clin Allergy. 1971 Mar;1(1):111-21 [PMID: 4262123]
  22. Med Welt. 1972 Jan 15;23(3):86-90 [PMID: 5018429]
  23. Arch Dermatol. 1971 Sep;104(3):254-9 [PMID: 4398554]
  24. Mayo Clin Proc. 1973 May;48(5):340-8 [PMID: 4267356]
  25. Arch Dermatol. 1970 Jun;101(6):642-5 [PMID: 4912758]
  26. Munch Med Wochenschr. 1968 Nov 1;110(44):2549-53 [PMID: 4238534]
  27. Z Haut Geschlechtskr. 1973 Jun;48(11):419-23 [PMID: 4123898]
  28. Acta Derm Venereol. 1968;48(6):578-88 [PMID: 4185296]
  29. Br J Dermatol. 1971 Jan;84(1):48-53 [PMID: 4929662]
  30. Clin Allergy. 1971 Mar;1(1):97-109 [PMID: 4403242]

MeSH Term

Antigen-Antibody Complex
Basement Membrane
Blood Vessels
Complement C1
Complement C3
Complement C5
Complement System Proteins
Female
Fluorescent Antibody Technique
Humans
Immunoglobulin A
Immunoglobulin G
Immunoglobulin M
Inflammation
Leukocytes
Male
Skin
Skin Diseases
Vascular Diseases

Chemicals

Antigen-Antibody Complex
Complement C1
Complement C3
Complement C5
Immunoglobulin A
Immunoglobulin G
Immunoglobulin M
Complement System Proteins

Word Cloud

Created with Highcharts 10.0.0cutaneouscomplementalpha2DlesionspatientsvasculitistestedoccurrenceC1qbeta1FIgGIgMvesselwallscasesfactorsUsingindirectdoublelayerimmunofluorescencemethodfreshskin10differentformscomplement-factorsC1C3C5contrastirregularlyfoundfixingimmunoglobulinsregularlyseenboundmostlyC3-factordemonstrablecombinedand/or25non-homogenousroddyfluoresceneceepidermalbasalmembranezonevesselsfindingssuggest"alternatepathway"beginningC3-activationfollowedwhereastypical"immunecomplexvasculitis"obviouslyrareconstantvascultisconsistentknownchemotacticdestructiveroleexperimentalmodelsangiitismaynecessarilyinvolvespecificimmunologicalprocessImmunofluorescentinvestigationsHistotopicaldemonstrationcomplement/complement

Similar Articles

Cited By (1)